September 2014

Comprehensive chromosome screening with synchronous blastocyst transfer Time for a paradigm shift

Recently, the nature of assisted reproductive technology (ART) laboratory investigation has been shifting. Traditionally, it has focused on optimizing the culture milieu or assuring fertilization; now, a variety of new technologies are available to assess the reproductive potential of individual embryos. Perhaps most prominent has been the resurgence of embryonic aneuploidy screening. The validation of 24-chromosome testing platforms has led to a variety of studies demonstrating higher implantation and delivery rates.
Published
Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
Like

Authors

Richard Scott Jr., M.D., Jason M. Franasiak, M.D., Eric J. Forman, M.D.

Volume 102, Issue 3, Pages 660-661

Abstract

Recently, the nature of assisted reproductive technology (ART) laboratory investigation has been shifting. Traditionally, it has focused on optimizing the culture milieu or assuring fertilization; now, a variety of new technologies are available to assess the reproductive potential of individual embryos. Perhaps most prominent has been the resurgence of embryonic aneuploidy screening. The validation of 24-chromosome testing platforms has led to a variety of studies demonstrating higher implantation and delivery rates.

Read the full text at: http://www.fertstert.org/article/S0015-0282(14)00568-8/fulltext


Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. 

Recommended Content